Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
Эпидемиология злокачественных новообразований желудочно-кишечного тракта: систематический анализ по данным исследования Global Burden of Disease 2021
2024-09-06
SCID: 54.1/yez56tc9
Discuss with AI
Global Burden of Disease Study 2021Sociodemographic Indexage-standardised death rateage-standardised incidence rategastrointestinal cancers
Figures from the paper
Abstract (AI)
BACKGROUND: Gastrointestinal cancers comprise nearly one-third of global mortality from cancer, yet the comprehensive global burden of these cancers remains uninvestigated. OBJECTIVE: We aimed to assess the global, regional and national burden of gastrointestinal cancers. DESIGNS: Data on oesophagus, gastric, colorectal, liver, pancreas and biliary tract cancers were extracted from the Global Burden of Disease 2021 database. Age-standardised incidence rate (ASIR) and age-standardised death rate (ASDR) were calculated by sex, region and Sociodemographic Index (SDI). RESULTS: In 2021, there were 5.26 million incidences and 3.70 million deaths from gastrointestinal cancer. The greatest burden is from colorectal, followed by gastric, oesophageal, pancreatic, liver and biliary tract cancer. We noted geographical and socioeconomic differences in ASIR and ASDR across all types of cancers. From 2000 to 2021, ASIR increased for colorectal cancer (annual percent change (APC): 0.10%, 95% CI 0.05% to 0.14%), pancreatic cancer (APC: 0.27%, 95% CI 0.14% to 0.41%), and liver cancer from metabolic dysfunction-associated steatotic liver disease (APC: 0.62%, 95% CI 0.58% to 0.67%) and alcohol-related liver disease (APC: 0.26%, 95% CI 0.22% to 0.30%). ASDR increased for pancreatic cancer (APC: 0.18%, 95% CI 0.02% to 0.34%). Higher SDI countries had higher incidence rates for most types of gastrointestinal cancer. CONCLUSIONS: Although the ASIR of oesophageal, gastric and biliary tract cancer has decreased, the ASIR still increased in colorectal, pancreatic and liver cancer from steatotic liver disease. Public policies are important for controlling gastrointestinal cancers-most importantly, reducing alcohol consumption, hepatitis B immunisation and tackling the burden of metabolic diseases.
Key Findings
1
Age-standardised incidence and death rates varied substantially by geography and socioeconomic development across gastrointestinal cancer types.
2
Colorectal cancer imposed the greatest gastrointestinal cancer burden, followed by gastric, oesophageal, pancreatic, liver and biliary tract cancers.
3
From 2000 to 2021, incidence increased for colorectal, pancreatic, and liver cancers related to metabolic dysfunction-associated steatotic liver disease and alcohol.
4
In 2021, gastrointestinal cancers caused 5.26 million incident cases and 3.70 million deaths globally.
5
Pancreatic cancer mortality increased over the same period, while oesophageal, gastric and biliary tract cancer incidence declined.
6
The findings support policies targeting alcohol reduction, hepatitis B immunisation, and metabolic disease prevention to control gastrointestinal cancers.
Research Object
Global gastrointestinal cancers, including oesophageal, gastric, colorectal, liver, pancreatic and biliary tract cancers, across global, regional and national populations
Research Subject
The geographical, socioeconomic and temporal patterns of incidence and mortality burden, measured by age-standardised incidence and death rates, by cancer type, sex, region and Sociodemographic Index
Publication Details
Publication Date
2024-09-06
Journal
Publisher
ISSN
Cited by
165
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192020
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 20212024
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 20192021
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 20192022